Gene · 291
Papers1,498
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,498
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Design of pattern-reconfigurable circularly polarized unidirectional antenna based on quasi-radiator for ISM applications. | Heliyon | 2022 | 36439733 | PubTator, text mining | PubMed |
| Herpes Simplex Type 1 UL43 Multiple Membrane-Spanning Protein Increases Energy Metabolism in Host Cells through Interacting with ARL2. | Cells | 2022 | 36429022 | PubTator, text mining | PubMed |
| Editorial: "Molecular mechanisms and physiological significance of organelle interactions and cooperation-Volume II". | Front Cell Dev Biol | 2022 | 36425529 | PubTator, text mining | PubMed |
| Recurrent acute myocarditis: An under-recognized clinical entity associated with the later diagnosis of a genetic arrhythmogenic cardiomyopathy. | Front Cardiovasc Med | 2022 | 36386348 | PubTator, text mining | PubMed |
| Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma. | Int J Mol Sci | 2022 | 36362420 | PubTator, text mining | PubMed |
| Mitochondrial Epilepsy, a Challenge for Neurologists. | Int J Mol Sci | 2022 | 36362003 | PubTator, text mining | PubMed |
| Differential Expression of lncRNA-miRNA-mRNA and Their Related Functional Networks in New-Onset Type 2 Diabetes Mellitus among Chinese Rural Adults. | Genes (Basel) | 2022 | 36360309 | PubTator, text mining | PubMed |
| Mitochondrial Cardiomyopathy: Molecular Epidemiology, Diagnosis, Models, and Therapeutic Management. | Cells | 2022 | 36359908 | PubTator, text mining | PubMed |
| Multiomics analyses reveals Anaplasma phagocytophilum Ats-1 induces anti-apoptosis and energy metabolism by upregulating the respiratory chain-mPTP axis in eukaryotic mitochondria. | BMC Microbiol | 2022 | 36357826 | PubTator, text mining | PubMed |
| Urine proteomic signatures predicting the progression from premalignancy to malignant gastric cancer. | EBioMedicine | 2022 | 36356476 | PubTator, text mining | PubMed |
| Mass spectrometry-based proteomics analysis of human globus pallidus from progressive supranuclear palsy patients discovers multiple disease pathways. | Clin Transl Med | 2022 | 36354133 | PubTator, text mining | PubMed |
| The prevalence of inherited metabolic disorders in Estonian population over 30 years: A significant increase during study period. | JIMD Rep | 2022 | 36341167 | PubTator, text mining | PubMed |
| Using a multiomics approach to unravel a septic shock specific signature in skeletal muscle. | Sci Rep | 2022 | 36335235 | PubTator, text mining | PubMed |
| The covalent reactivity of functionalized 5-hydroxy-butyrolactams is the basis for targeting of fatty acid binding protein 5 (FABP5) by the neurotrophic agent MT-21. | RSC Chem Biol | 2022 | 36320884 | PubTator, text mining | PubMed |
| Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis. | Front Oncol | 2022 | 36313709 | PubTator, text mining | PubMed |
| Miniaturized Folded-Slot CubeSat MIMO Antenna Design with Pattern Diversity. | Sensors (Basel) | 2022 | 36298204 | PubTator, text mining | PubMed |
| The Credible Role of Curcumin in Oxidative Stress-Mediated Mitochondrial Dysfunction in Mammals. | Biomolecules | 2022 | 36291614 | PubTator, text mining | PubMed |
| Identifying and Targeting Prediction of the PI3K-AKT Signaling Pathway in Drug-Induced Thrombocytopenia in Infected Patients Receiving Linezolid Therapy: A Network Pharmacology-Based Analysis. | J Healthc Eng | 2022 | 36285187 | PubTator, text mining | PubMed |
| Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) and Its Correlation with Immune Infiltration in Pan-Cancer. | Biomed Res Int | 2022 | 36254139 | PubTator, text mining | PubMed |
| A novel variant in the HX repeat motif of ATN1 in a Chinese patient with CHEDDA syndrome and literature review. | Mol Genet Genomic Med | 2022 | 36251950 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/291/papers?page=12